|
⚲
|
| Keyboard |
| Clene Inc | |
|---|---|
| Ticker | CLNN |
| CIK # | 0001822791 |
| CUSIP | 185634201 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 6550 South Millrock Drive, Suite G50, Salt Lake City, UT 84121 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Clene Inc | 2024-10-09 | 7.3 M | Exemption: 506(b) · Duration: One year or less · Commission: $436,630 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001822791] | 10-K | |
| [0001822791] | 10-Q | |
| [0001822791] | 3 | |
| [0001822791] | 4 | |
| [0001822791] | 5 | |
| [0001822791] | 8-K | |
| [0001822791] | D | |
| [0001822791] | SC 13D | |
| [0001822791] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Armistice Capital LLC | Clene Inc | [2024-11-14] | 8.77 |
| AWM Investment Company Inc | Clene Inc | [2024-02-14] | 9.2 |
| Ugwumba Chidozie | Clene Inc | [2023-09-11] | 19.9 |
| Citadel Advisors LLC | Clene Inc | [2023-07-03] | 5.7 |
| Vivo Opportunity Fund Holdings LP | Clene Inc | [2023-06-28] | 9.99 |
| Foley & Lardner/ FA | Clene Inc | [2023-02-06] | 7.6 |
| Ugwumba Chidozie | Clene Inc | [2022-02-14] | 7.42 |
| Mosca Alison | Clene Inc | [2022-02-14] | 8.7 |
| Walton Thomas Layton | Clene Inc | [2022-02-14] | 0.0 |
| General Resonance LLC | Clene Inc | [2021-08-06] | 26.8 |
| 4Life Research LLC | Clene Inc | [2021-02-12] | 6.71 |
| Walton Thomas Layton | Clene Inc | [2021-01-15] | 6.3 |
| AK Holding Company LC | Clene Inc | [2021-01-11] | 8.63 |
| United Therapeutics Corp | Clene Inc | [2021-01-08] | 7.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ugwumba Chidozie
Common Stock
|
2026-03-31 | Sell | 67,991 | $4.88 | 331,796 |
|
Ugwumba Chidozie
Common Stock
|
2026-03-30 | Sell | 15,536 | $5.10 | 79,234 |
|
Ugwumba Chidozie
Common Stock
|
2026-03-27 | Sell | 17,470 | $4.75 | 82,982 |
|
Ugwumba Chidozie
Common Stock
|
2026-03-26 | Sell | 5,319 | $5.40 | 28,723 |
|
Ugwumba Chidozie
Common Stock
|
2026-03-25 | Sell | 7,098 | $5.50 | 39,039 |
|
Ugwumba Chidozie
Common Stock
|
2026-03-24 | Sell | 5,492 | $5.78 | 31,744 |
|
Mosca Alison
stock option · derivative
|
2026-02-19 | Grant | 4,201 | $0.00 | |
|
Kiernan Matthew
stock option · derivative
|
2026-02-19 | Grant | 2,755 | $0.00 | |
|
Gay Jonathon
stock option · derivative
|
2026-02-19 | Grant | 3,271 | $0.00 | |
|
Jacobovitz Shalom
stock option · derivative
|
2026-02-19 | Grant | 4,098 | $0.00 | |
|
Matlin David J
stock option · derivative
|
2026-02-19 | Grant | 5,372 | $0.00 | |
|
McLaughlin Vallerie
stock option · derivative
|
2026-02-19 | Grant | 3,030 | $0.00 | |
|
Desai Arjun JJ
stock option · derivative
|
2026-02-19 | Grant | 3,168 | $0.00 | |
|
Wilcox Reed N
stock option · derivative
|
2026-02-19 | Grant | 3,306 | $0.00 | |
|
Ugwumba Chidozie
Common Stock
|
2026-02-03 | Sell | 5,559 | $4.10 | 22,792 |
|
Ugwumba Chidozie
Common Stock
|
2026-02-02 | Sell | 3,800 | $4.04 | 15,352 |
|
Ugwumba Chidozie
Common Stock
|
2026-01-30 | Sell | 5,686 | $4.13 | 23,483 |
|
Ugwumba Chidozie
Common Stock
|
2026-01-29 | Sell | 15,284 | $4.32 | 66,027 |
|
Ugwumba Chidozie
Common Stock
|
2026-01-28 | Sell | 8,717 | $4.91 | 42,800 |
|
Ugwumba Chidozie
Common Stock
|
2026-01-27 | Sell | 4,139 | $5.08 | 21,026 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 29 | 2,193,637 |
| 2025-12-31 | 28 | 1,987,358 |
| 2025-09-30 | 29 | 783,757 |
| 2025-06-30 | 24 | 580,615 |
| 2025-03-31 | 25 | 455,424 |
| 2024-12-31 | 29 | 585,506 |
| 2024-09-30 | 22 | 1,112,148 |
| 2024-06-30 | 38 | 7,177,203 |
| 2024-03-31 | 45 | 8,154,077 |
| 2023-12-31 | 47 | 12,363,764 |
| 2023-09-30 | 48 | 25,091,428 |
| 2023-06-30 | 51 | 32,716,924 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Penn Davis McFarland Inc | [2026-06-30] | SOLE | 11,000 | 11,000 | Prev | Page 1 | Next |